{
    "clinical_study": {
        "@rank": "156222", 
        "arm_group": {
            "arm_group_label": "Ropivacaine", 
            "arm_group_type": "Experimental", 
            "description": "Unilateral transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)"
        }, 
        "brief_summary": {
            "textblock": "In this study we investigate the following properties of the transversus abdominis plane\n      block in healthy volunteers:\n\n        1. Cutaneous analgesic distribution\n\n        2. Muscular affection\n\n        3. Reproducibility"
        }, 
        "brief_title": "A Study Investigating Properties of the Transversus Abdominis Plane Block", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Anesthesia, Local", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Capable\n\n          -  American society of anesthesiologists classification 1 or 2\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Age below 18 years\n\n          -  American society of anesthesiologists classification above 2\n\n          -  Body weight below 50 kg\n\n          -  Body mass index > 35 kg/m2\n\n          -  Previous abdominal surgery\n\n          -  Acute or chronic pain\n\n          -  Use of pain medication less than 24 h prior to study start\n\n          -  Allergy to local anesthetics\n\n          -  Pregnancy\n\n          -  Breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679392", 
            "org_study_id": "H-1-2011-030", 
            "secondary_id": "2011-004719-22"
        }, 
        "intervention": {
            "arm_group_label": "Ropivacaine", 
            "description": "Unilateral, single shot, ultrasound-guided, transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)", 
            "intervention_name": "Ropivacaine", 
            "intervention_type": "Drug", 
            "other_name": "Naropin"
        }, 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Transversus abdominis plane block", 
            "Ultrasound guided nerve block"
        ], 
        "lastchanged_date": "September 5, 2012", 
        "location": {
            "contact": {
                "email": "kstoeving@gmail.com", 
                "last_name": "Kion Bo St\u00f8ving, MD", 
                "phone": "+4531141627"
            }, 
            "facility": {
                "address": {
                    "city": "Hiller\u00f8d", 
                    "country": "Denmark", 
                    "zip": "3400"
                }, 
                "name": "Hiller\u00f8d Hospital"
            }, 
            "investigator": {
                "last_name": "Kion Bo St\u00f8ving, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "official_title": "Transversus Abdominis Plane Block: A Placebo-controlled Study in Healthy Volunteers", 
        "overall_contact": {
            "email": "kstoeving@gmail.com", 
            "last_name": "Kion Bo St\u00f8ving, MD", 
            "phone": "+4531141627"
        }, 
        "overall_contact_backup": {
            "email": "klangedk@gmail.com", 
            "last_name": "Kai Lange, MD", 
            "phone": "+4531909730"
        }, 
        "overall_official": [
            {
                "affiliation": "Hillerod Hospital, Denmark", 
                "last_name": "Kion Bo St\u00f8ving, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hillerod Hospital, Denmark", 
                "last_name": "Charlotte Rosenstock, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Hillerod Hospital, Denmark", 
                "last_name": "Kai Lange, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: The Regional Committee on Biomedical Research Ethics", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cutaneous analgesic distribution 90 min after transversus abdominis plane block administration", 
            "measure": "Cutaneous analgesic distribution", 
            "safety_issue": "No", 
            "time_frame": "90 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679392"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hillerod Hospital, Denmark", 
            "investigator_full_name": "Kai Henrik Wiborg Lange", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Abdominal wall muscle affection of the transversus abdominal plane block measured by ultrasonography under standardized conditions", 
                "measure": "Muscular affection of the transversus abdominis plane block", 
                "safety_issue": "No", 
                "time_frame": "90 min"
            }, 
            {
                "description": "Reproducibility of the transversus abdominis plane block with respect to:\nCutaneous analgesic distribution\nAbdominal wall muscle affection measured in the same individual separated by at least 2 days", 
                "measure": "Reproducibility of the transversus abdominis plane block", 
                "safety_issue": "No", 
                "time_frame": "At least 2 days"
            }
        ], 
        "source": "Hillerod Hospital, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hillerod Hospital, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}